Oticon Real vs Resound Vivia 9 60S microRIE

The Oticon Real is a premium behind-the-ear prescription hearing aid released in 2023, currently available at $4,798. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.8/5, placing it in the top 8% of all prescription hearing aids tested and ranking #4 out of 36 devices in its category. Speech performance is a standout strength. Speech in quiet scores an excellent 4.5/5 on initial fit—0.72 points above the category average—while speech in noise scores 3.0/5, nearly a full point above the category average of 1.96/5. While the speech-in-noise result is above average for the category, it remains mixed in absolute terms at 2.9/5 after tuning, reflecting the inherent challenge of noisy environments for all hearing aids. Music streaming quality starts strong at 4.2/5 on initial fit, though it drops to a mixed 2.8/5 after tuning—still slightly above the category average. Feedback handling scores a solid 4.0/5, which is strong in absolute terms, though it falls 0.71 points below the category average of 4.71/5. Own-voice comfort is mixed at 2.4/5, slightly below the category average. The Oticon Real competes directly with other premium devices like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5). It offers versatile connectivity with iPhone and Android streaming plus hands-free capabilities, and supports both rechargeable and disposable batteries. This device is best suited for users prioritizing strong out-of-box speech clarity who want a well-rounded premium hearing aid from a trusted manufacturer.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.